Application

RLF-100

Relief Therapeutics Holding AG

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90141290
Filing Date: 08/27/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90141290
MARK INFORMATION
*MARK RLF-100
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT RLF-100
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Relief Therapeutics Holding AG
*MAILING ADDRESS 390 Park Avenue
*CITY New York
*STATE
(Required for U.S. applicants)
New York
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
10022
*DOMICILE XXXX
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Switzerland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 08/26/2020
       FIRST USE IN COMMERCE DATE At least as early as 08/26/2020
       SPECIMEN FILE NAME(S) \\TICRS\EXPORT18\IMAGEOUT 18\901\412\90141290\xml1 \ APP0003.JPG
       SPECIMEN DESCRIPTION RLF-100 drug for treating COVID-19
ATTORNEY INFORMATION
NAME Heather M. Schneider
ATTORNEY DOCKET NUMBER 127525.00001
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Willkie Farr & Gallagher LLP
STREET 787 Seventh Avenue
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10019
PHONE 212-728-8685
EMAIL ADDRESS ipdept@willkie.com
OTHER APPOINTED ATTORNEY Eugene Chang, Spencer Simon, Matthew Makover, Khalil Nobles, Eric Saunders, Yoon Jung, Daniel Werb & Kelsie Kelly
CORRESPONDENCE INFORMATION
NAME Heather M. Schneider
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ipdept@willkie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) hschneider@willkie.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /Heather M. Schneider/
SIGNATORY'S NAME Heather M. Schneider
SIGNATORY'S POSITION Attorney of Record, New York Bar member
SIGNATORY'S PHONE NUMBER 217-728-8685
DATE SIGNED 08/27/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90141290
Filing Date: 08/27/2020

To the Commissioner for Trademarks:

MARK: RLF-100 (Standard Characters, see mark)
The literal element of the mark consists of RLF-100. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Relief Therapeutics Holding AG, a corporation of Switzerland, having an address of
      390 Park Avenue
      New York, New York 10022
      United States
      XXXX
Domiciled at: XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 08/26/2020, and first used in commerce at least as early as 08/26/2020, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) RLF-100 drug for treating COVID-19.
Specimen File1



The owner's/holder's proposed attorney information: Heather M. Schneider. Other appointed attorneys are Eugene Chang, Spencer Simon, Matthew Makover, Khalil Nobles, Eric Saunders, Yoon Jung, Daniel Werb & Kelsie Kelly. Heather M. Schneider of Willkie Farr & Gallagher LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      787 Seventh Avenue
      New York, New York 10019
      United States
      212-728-8685(phone)
      ipdept@willkie.com
The docket/reference number is 127525.00001.
Heather M. Schneider submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Heather M. Schneider
       PRIMARY EMAIL FOR CORRESPONDENCE: ipdept@willkie.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): hschneider@willkie.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Heather M. Schneider/   Date: 08/27/2020
Signatory's Name: Heather M. Schneider
Signatory's Position: Attorney of Record, New York Bar member
Payment Sale Number: 90141290
Payment Accounting Date: 08/27/2020

Serial Number: 90141290
Internet Transmission Date: Thu Aug 27 10:04:19 ET 2020
TEAS Stamp: USPTO/BAS-X.XX.XX.XXX-202008271004194179
19-90141290-74035822ba994be6821546fe6e33
99f9f89ff0d6af12f9e8f9fbfb8c8a441cb9a1-D
A-04194115-20200827100117353302

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed